ENDOCYTE INC 3 SEC Filings

Filed On	Filing
15 Nov 2018	Form 3: McAvoy David R., General Counsel Holds 24,185 shares of Common Stock
04 May 2018	Form 3: Svoronos Dawn, Director No securities owned
01 Mar 2018	Form 3: Machado Patrick, Director No securities owned
08 Feb 2018	Form 3: Chelius Erik C., Vice President CMC Holds 38,159 shares of Common Stock
22 Feb 2017	Form 3: Andriole Michael T., Chief Financial Officer No securities owned
04 Aug 2015	Form 3: Armour Alison A., Chief Medical Officer No securities owned
13 Feb 2015	Form 3: Parker Katherine, VP of Human Resources Holds 10,000 shares of Common Stock
08 Nov 2013	Form 3: Goddard Colin, Director No securities owned
21 Jun 2013	Form 3: Brinkley Michael A., VP OF QUALITY ASSURANCE
21 Jun 2013	Form 3: Harper Scot, VP of CLINICAL OPERATIONS
08 Jan 2013	Form 3: Russell Lesley, Director No securities owned
07 Aug 2012	Form 3: Meek David D., Chief Commercial Officer No securities owned
26 Jul 2012	Form 3: Kozin Marc D, Director No securities owned
04 Jun 2012	Form 3: Meldrum Peter D, Director No securities owned
28 Jun 2011	Form 3: Nguyen Binh, VP of Clinical Affairs
03 Jun 2011	Form 3: Taylor Beth, Corporate Controller Holds 1,722 shares of Common Stock
04 Feb 2011	Form 3: Sherman Michael A., Chief Financial Officer Holds 52,356 shares of Common Stock
04 Feb 2011	Form 3: Shannon James Samuel, Director
04 Feb 2011	Form 3: Sanderling Ventures Management V, 10% owner and 1 other Holds 83,769 shares of Common Stock
04 Feb 2011	Form 3: Sanderling Venture Partners V, Lp, 10% owner and 8 others Holds 136,473 shares of Common Stock

Comments